531541 KOBO

Kobo Biotech Share Price

 

 

Start SIP in KOBO

Start SIP

Performance

  • Low
  • ₹3
  • High
  • ₹3
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹4
  • Open Price₹3
  • Previous Close₹3
  • Volume6,223
  • 50 DMA₹2.59
  • 100 DMA₹2.55
  • 200 DMA₹2.63

Investment Returns

  • Over 1 Month + 31.96%
  • Over 3 Month -7.07%
  • Over 6 Month + 18.93%
  • Over 1 Year + 6.64%

Smart Investing Starts Here Start SIP with Kobo Biotech for Steady Growth!

Invest Now

Kobo Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.4
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 7
  • P/B Ratio
  • -0.1
  • Average True Range
  • 0.17
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.13
  • RSI
  • 60.06
  • MFI
  • 88.36

Kobo Biotech Financials

Kobo Biotech Technicals

EMA & SMA

Current Price
₹2.89
0 (0%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹2.75
  • 50 Day
  • ₹2.59
  • 100 Day
  • ₹2.55
  • 200 Day
  • ₹2.63

Resistance and Support

2.93 Pivot Speed
  • R3 3.07
  • R2 3.04
  • R1 2.96
  • S1 2.85
  • S2 2.82
  • S3 2.74

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kobo Biotech has an operating revenue of Rs. 32.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 0% needs improvement, NULL It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kobo Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results
2023-08-11 Quarterly Results

Kobo Biotech F&O

Kobo Biotech Shareholding Pattern

44.95%
0%
47.9%
7.15%

Kobo Biotech FAQs

Kobo Biotech share price is ₹2 As on 17 February, 2026 | 00:43

The Market Cap of Kobo Biotech is ₹6.9 Cr As on 17 February, 2026 | 00:43

The P/E ratio of Kobo Biotech is -1.4 As on 17 February, 2026 | 00:43

The PB ratio of Kobo Biotech is -0.1 As on 17 February, 2026 | 00:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23